Navigation Links
Quintiles to Open Clinical Research Office in Wilmington, NC
Date:1/17/2008

Growth driving second new office opening in North Carolina in last 12

months

RESEARCH TRIANGLE PARK, N.C., Jan. 17 /PRNewswire/ -- Quintiles Transnational Corp. today announced that the global leader in pharmaceutical services will open an office in Wilmington, N.C. The new office is an expansion of Quintiles' clinical research in pharmaceutical and biotechnology development.

The new Wilmington office is Quintiles' second expansion within the state in the last 12 months. Last January, Quintiles opened a data processing center in Williamston, N.C.

"With a strong educational system and a positive environment for business, North Carolina is clearly the leading location for global clinical research organizations," said Mike Mortimer, Executive Vice President and Chief Administrative Officer. "We were founded in the Research Triangle more than 25 years ago, and we've fueled our growth by tapping into an excellent work force like that in North Carolina, with people committed to improving health care around the world. Our employees find Quintiles to be a place for fulfilling, rewarding work and in return they are driving the company to great success."

The Wilmington office is centrally located in the North State Bank Building, 1411 Commonwealth Drive, convenient to major thoroughfares and the Wilmington airport, and not far from Wrightsville Beach. Quintiles will occupy two of the three stories of the bank building.

Founded in 1982 by current CEO and Chairman Dennis Gillings, CBE, the company is considered a pioneer in clinical research. Quintiles is the largest provider of pharmaceutical services in the world, with more than 19,000 employees in more than 50 countries. More than 1,500 are employed in North Carolina.

About Quintiles

Quintiles Transnational Corp. is powering the next generation of healthcare by providing a broad range of professional services in drug development, fina
'/>"/>

SOURCE Quintiles Transnational Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Quintiles Central Lab, Clinical Development in China to Expand, Relocate to New Facility
2. Quintiles Names Kelly McKee Executive Director of Operations for Public Health and Government Services Unit
3. Expert Cardiologist Joins Quintiles Medical Group
4. Michael Troullis Appointed Chief Financial Officer of Quintiles Transnational Corp.
5. YM BioSciences provides update on AeroLEF(TM) clinical development program
6. Irving Dark Named Vice President of Cytel Clinical Research Services
7. Helix BioPharma Corp. contracts KBI Biopharma to develop an L-DOS47 clinical packaging format
8. GelVac(TM) Nasal Powder H5N1 (Bird Flu) Influenza Vaccine Passes Preclinical Toxicology Studies
9. Premier Research Names Patrick Melvin as Senior Director, Clinical Trial Management
10. A New, Unique and Unrivalled Rat/Mouse PINP Assay for Pharmaceutical, Clinical and Academic Research Organizations.
11. Association of Clinical Research Organizations (ACRO) Elects New Officers for 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2015)... Aug. 26, 2015  Roka Bioscience, Inc. (NASDAQ: ... advanced testing solutions for the detection of foodborne pathogens, ... at the Sidoti & Company Emerging Growth Conference on ... held at the New York Marriott Marquis. ... available through the investor relations section of Roka Bioscience,s ...
(Date:8/26/2015)... -- The Diabetes Research Institute (DRI), a Center of ... of Medicine, announced today that the first patient ... first time a novel transplant technique for insulin-producing ... I/II study builds upon decades of progress in ... step toward the development of the DRI BioHub, ...
(Date:8/26/2015)... , Aug. 26, 2015 Intrexon Corporation ... announced today the closing of its previously announced public ... by the underwriters of their option to purchase an ... offering price of $41.00 per share.  The exercise of ... of common stock sold by Intrexon to 5,609,756 shares ...
(Date:8/26/2015)... , Aug. 26, 2015 China Cord ... China,s leading provider of cord blood ... cell storage services, today announced that the Company has ... ("MO2"), an entity wholly owned by Mr. Yuen Kam, ... has acquired the outstanding shares (the "Shares") of  Excellent ...
Breaking Biology Technology:Diabetes Research Institute Successfully Transplants First Patient In Pilot BioHub Trial 2Diabetes Research Institute Successfully Transplants First Patient In Pilot BioHub Trial 3Diabetes Research Institute Successfully Transplants First Patient In Pilot BioHub Trial 4Intrexon Announces Closing of $230 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares 2Intrexon Announces Closing of $230 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares 3Intrexon Announces Closing of $230 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares 4China Cord Blood Corporation Receives Notice of Transactions Regarding its 7% Senior Convertible Notes Due 2017 2China Cord Blood Corporation Receives Notice of Transactions Regarding its 7% Senior Convertible Notes Due 2017 3
... ImQuest Life Sciences today presented important new ... small molecules as antiviral agents at the 13th ... meeting held last week in Washington D.C. ... inhibitors of HBV replication, with two compounds yielding ...
... Pharmaceuticals, Inc. (NASDAQ: ANPI , TSX: ... and Restated Distribution and License Agreement with its ... the Amended and Restated Distribution and License Agreement, ... Baxter initially entered into a Distribution and License ...
... ST. JOSEPH, Mich., March 31 GeneGo, Inc., the ... Webb, Ph.D., director of the Program of Translational Medicine ... the MetaMiner Oncology Partnership Program. The goal of ... pathway analysis platform built by experts in the ...
Cached Biology Technology:ImQuest Presents Data on the Anti-Hepatitis B Virus Activity of Pyrimidinediones at the 13th ISVHLD Meeting in Washington D.C. 2Angiotech Pharmaceuticals, Inc. announces License Agreement with Baxter International Inc. 2Angiotech Pharmaceuticals, Inc. announces License Agreement with Baxter International Inc. 3Angiotech Pharmaceuticals, Inc. announces License Agreement with Baxter International Inc. 4Van Andel Institute Joins the MetaMiner Oncology Partnership Program 2Van Andel Institute Joins the MetaMiner Oncology Partnership Program 3
(Date:8/4/2015)... ) today reported financial and operating results for the second quarter ... quarter contract revenue of $ 85.2 million, a ... of 26 % , Second quarter adjusted ... royalties in the current quarter , Operating cash ... to present another strong financial quarter, with all our divisions achieving ...
(Date:7/31/2015)... , 31 de julho de 2015 ... www.icg-10.org ) será realizada pela BGI de 22-25 de ... . A conferência está celebrando seu 10 ... 2006, a ICG se tornou uma das reuniões mais ... dos encontros científicos mais dinâmicos, entusiastas e prazerosos. ...
(Date:7/31/2015)... OXFORD, Conn. , Jul. 31, 2015 NXT-ID, ... a biometric authentication company focused on the growing mobile ... announces that it has filed provisional patent 62/198989 for ... This invention highlights a method to advance crypto-currencies ... technology by introducing a common, uniform way to manage ...
Breaking Biology News(10 mins):AMRI Announces Second Quarter 2015 Results 2AMRI Announces Second Quarter 2015 Results 3AMRI Announces Second Quarter 2015 Results 4AMRI Announces Second Quarter 2015 Results 5AMRI Announces Second Quarter 2015 Results 6AMRI Announces Second Quarter 2015 Results 7AMRI Announces Second Quarter 2015 Results 8AMRI Announces Second Quarter 2015 Results 9AMRI Announces Second Quarter 2015 Results 10AMRI Announces Second Quarter 2015 Results 11AMRI Announces Second Quarter 2015 Results 12AMRI Announces Second Quarter 2015 Results 13AMRI Announces Second Quarter 2015 Results 14AMRI Announces Second Quarter 2015 Results 15AMRI Announces Second Quarter 2015 Results 16AMRI Announces Second Quarter 2015 Results 17AMRI Announces Second Quarter 2015 Results 18AMRI Announces Second Quarter 2015 Results 19AMRI Announces Second Quarter 2015 Results 20AMRI Announces Second Quarter 2015 Results 21AMRI Announces Second Quarter 2015 Results 22AMRI Announces Second Quarter 2015 Results 23AMRI Announces Second Quarter 2015 Results 24A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 3NXT-ID Patents Electronic Crypto-Currency Management Technology 2NXT-ID Patents Electronic Crypto-Currency Management Technology 3NXT-ID Patents Electronic Crypto-Currency Management Technology 4
... the Carnegie Institution's Department of Plant Biology have ... nutrient regulation—neighboring pore-like structures at the cell's surface ... vital nutrient, nitrogen. It is the first time ... molecules is essential to this regulation. Since plants, ...
... don’t necessarily rest quietly until invading bacteria lock onto ... action, as previously thought. In a new paper, University ... barge inside these guard cells and independently initiate a ... ahead of print in the April issue of the ...
... and smiling, but this cheerful demeanor masks serious neurological ... ,ew research in mice, however, suggests that many ... Weeber, Ph.D., and colleagues reversed the neurological deficits in ... inhibition of CaMKII, an enzyme highly expressed in brain ...
Cached Biology News:New mechanism for nutrient uptake discovered 2New mechanism for nutrient uptake discovered 3Microbes start immune response by sneaking inside cells 2Angelman syndrome deficits rescued in mice 2Angelman syndrome deficits rescued in mice 3
MOUSE ANTI BOVINE WC1:FITC Immunogen: Bovine lymphocytes...
ANTI S. ENTERID LPS...
... ELISA Development kit contains the basic components ... to measure natural and recombinant Feline IL-10 ... kit contains sufficient materials to run ELISAs ... the following conditions are met: The ...
... DuoSet ELISA Development kit contains the basic ... ELISAs to measure natural and recombinant rat ... Each kit contains sufficient materials to ... provided that the following conditions are met: ...
Biology Products: